ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients (Q37038635)

17 August 2017

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

9

Diethelm Wallwiener

0 references

Annette Staebler

8

Annette Staebler

0 references

Silke Dürr-Störzer

5

Silke Dürr-Störzer

0 references

Graziella Becker-Pergola

4

Graziella Becker-Pergola

0 references

Tanja Fehm

1

Tanja Fehm

0 references

Erich-Franz Solomayer

3

Erich-Franz Solomayer

0 references

author name string

Natalia Krawczyk

2

1 reference

17 August 2017

Hans Neubauer

6

1 reference

17 August 2017

Harald Seeger

7

1 reference

17 August 2017

Sven Becker

10

1 reference

17 August 2017

15 September 2008

1 reference

17 August 2017

Breast Cancer Research

1 reference

17 August 2017

10

1 reference

17 August 2017

R76

1 reference

17 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2143

17 August 2017

0 references

cites work

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Breast cancer, stem/progenitor cells and the estrogen receptor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Prospective identification of tumorigenic breast cancer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Stem cells, cancer, and cancer stem cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Steroid hormone receptor status of mouse mammary stem cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

A pooled analysis of bone marrow micrometastasis in breast cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Impact of metastatic estrogen receptor and progesterone receptor status on survival

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression*.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Variability of oestrogen and progesterone receptor status between primary breast cancer and nodal metastases: preliminary communication.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614509

Random mutations, selected mutations: A PIN opens the door to new genetic landscapes

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2143

Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome

21 January 2018

1 reference

12 December 2020

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

1 reference

12 December 2020

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients

1 reference

12 December 2020

Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells

1 reference

12 December 2020

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

12 December 2020

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

12 December 2020

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients

1 reference

12 December 2020

Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice

1 reference

12 December 2020

Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival

1 reference

12 December 2020

Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer

1 reference

12 December 2020

Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells

1 reference

12 December 2020

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells

1 reference

12 December 2020

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

1 reference

12 December 2020

Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2143

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference